Fundz

Optellum, Ai Lung Cancer Diagnosis Innovator, Secures $14M Series A Funding To Accelerate Expansion

PRIVATESep 27, 2022

Amount Raised

$14 Million

Round Type

Series A

OxfordshireBiotechnologySoftwareHealth CareArtificial IntelligenceMedicalMachine LearningHealth Diagnostics

Description

Optellum, an Oxford-based medtech company that provides a breakthrough AI platform to diagnose and treat early-stage lung cancer, has raised $14 million in a Series A funding round. The investment will enable Optellum to scale its base, operations, and commercial launches in the UK and USA; accelerate research and development; and expand its platform into personalized therapy decisions by integrating imaging data with molecular data, robotics, and liquid biopsies.

Quick answer

Optellum raised $14 Million in a Series A round, dated September 27, 2022. Optellum is based in Oxfordshire, United Kingdom.

How much did Optellum raise?
Optellum raised $14 Million in a Series A round on September 27, 2022.
What does Optellum do?
Optellum was founded so that every lung cancer patient is treated at the earliest possible stage, and cured.
Where is Optellum based and how big is it?
Optellum is based in Oxfordshire, United Kingdom.

Source: Fundz verified event record.

Who else raised in Medical and Health Diagnostics around the same time

Companies in the same sectors as Optellum that raised within 45 days of this round, from Fundz verified event records.

  • Ibex Medical Analytics raised $10M (Funding Round) on November 9, 2022.
  • Carta Healthcare raised $20M (Series B) on November 2, 2022.
  • WhizAI raised an undisclosed amount on October 25, 2022.
  • DocSpera raised $10M (Funding Round) on September 27, 2022.
  • Incepto raised $27M (Funding Round) on September 19, 2022.
  • Adastra raised an undisclosed amount on August 22, 2022.

Who to call at Optellum, and when

A new round usually means Optellum is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Optellum raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Optellum, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Optellum. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Optellum

Location

Oxfordshire, United Kingdom

About

Optellum was founded so that every lung cancer patient is treated at the earliest possible stage, and cured. We are redefining early interception of lung disease, by enabling every clinician, in every hospital, to manage their patients in the optimal way. Our first product is the first Clinical Decision Support software for personalized early diagnosis & treatment of lung cancer, based on Artificial Intelligence & Machine Learning applied to the world’s largest clinical dataset. We are a team of world-leading medical imaging software, AI, and clinical experts who met at Oxford’s world-renowned computer vision laboratory. Between us, we have track records of bringing innovation to market through over 10 start-up companies, resulting already in 5 trade-sales and one IPO. We are backed by an Advisory Board comprising world-leading clinicians (global authors of medical guidelines) and experts in deep learning. We are building up our development team – join our fight against cancer, working together with former software engineers from top technology companies (Amazon, Facebook, Redhat) and veterans of medical imaging startups.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Optellum raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Optellum's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Optellum raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.